Diallyllysergamide

Diallyllysergamide
Clinical data
Other namesDAL, Lysergic acid diallylamide, d-lysergic acid diallylamide, d-diallyllysergamide
Routes of
administration		Oral
ATC code
  • none
Legal status
Legal status
  • US: Analogue to a Schedule I/II drug (but only if it is intended for human consumption)
Pharmacokinetic data
Metabolismhepatic
Excretionrenal
Identifiers
IUPAC name
  • (6aR,9R)-N,N-Diallyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo-[4,3-fg]quinoline-9-carboxamide
PubChem CID
ChemSpider
Chemical and physical data
FormulaC22H25N3O
Molar mass347.462 g·mol−1
3D model (JSmol)
SMILES
  • C=CCN(CC=C)C(=O)[C@@H]2C=C1c3cccc4[nH]cc(C[C@H]1N(C)C2)c34
InChI
  • InChI=1S/C22H25N3O/c1-4-9-25(10-5-2)22(26)16-11-18-17-7-6-8-19-21(17)15(13-23-19)12-20(18)24(3)14-16/h4-8,11,13,16,20,23H,1-2,9-10,12,14H2,3H3/t16-,20-/m1/s1 checkY
  • Key:VAMQYGHNZLRSSA-OXQOHEQNSA-N checkY
  (verify)

N,N-Diallyllysergamide (DAL, as the tartrate salt) is a psychedelic lysergamide. In their book TiHKAL, Alexander and Ann Shulgin describe it as being "an order of magnitude less potent than LSD itself".

References



    This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.